4D Pharma PLC LBPSW:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/09/21 EDT
1.25quote price arrow down-0.04 (-3.10%)
Volume
25,071
52 week range
1.00 - 1.76

...

Loading . . .
  • Open1.25
  • Day High1.27
  • Day Low1.25
  • Prev Close1.29
  • 52 Week High1.76
  • 52 Week High Date03/23/21
  • 52 Week Low1.00
  • 52 Week Low Date03/23/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open1.25
  • Day High1.27
  • Day Low1.25
  • Prev Close1.29
  • 52 Week High1.76
  • 52 Week High Date03/23/21
  • 52 Week Low1.00
  • 52 Week Low Date03/23/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From 4D Pharma PLC

There is no recent news for this security.

Profile

MORE
4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved...
Axel Glasmacher M.D.
Non-Executive Chairman
Duncan Peyton
Chief Executive Officer
John Beck Sr., CPA
Chief Financial Officer
Address
9 Bond Court
Leeds
LS1 2JZ
United Kingdom